732 related articles for article (PubMed ID: 29584449)
1. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD.
Hadi A; Mohammadi H; Miraghajani M; Ghaedi E
Crit Rev Food Sci Nutr; 2019; 59(15):2494-2505. PubMed ID: 29584449
[No Abstract] [Full Text] [Related]
2. The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis.
Khan MY; Mihali AB; Rawala MS; Aslam A; Siddiqui WJ
Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):703-715. PubMed ID: 31009401
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
Liu L; Li P; Liu Y; Zhang Y
Dig Dis Sci; 2019 Dec; 64(12):3402-3412. PubMed ID: 31203554
[TBL] [Abstract][Full Text] [Related]
4. Effects of probiotic supplementation on anthropometric and metabolic characteristics in adults with metabolic syndrome: A systematic review and meta-analysis of randomized clinical trials.
Hadi A; Arab A; Khalesi S; Rafie N; Kafeshani M; Kazemi M
Clin Nutr; 2021 Jul; 40(7):4662-4673. PubMed ID: 34237694
[TBL] [Abstract][Full Text] [Related]
5. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term synbiotic supplementation in addition to lifestyle changes in children with obesity-related non-alcoholic fatty liver disease.
Çakır M; Aksel İşbilen A; Eyüpoğlu İ; Sağ E; Örem A; Mazlum Şen T; Kaklıkkaya N; Kaya G
Turk J Gastroenterol; 2017 Sep; 28(5):377-383. PubMed ID: 28797988
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
Front Immunol; 2022; 13():949746. PubMed ID: 36159792
[TBL] [Abstract][Full Text] [Related]
8. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
[TBL] [Abstract][Full Text] [Related]
9. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
Daneshi-Maskooni M; Keshavarz SA; Mansouri S; Qorbani M; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
Trials; 2017 Jun; 18(1):260. PubMed ID: 28592311
[TBL] [Abstract][Full Text] [Related]
10. The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Jalali M; Mahmoodi M; Mosallanezhad Z; Jalali R; Imanieh MH; Moosavian SP
Complement Ther Med; 2020 Jan; 48():102283. PubMed ID: 31987259
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Guo XF; Wang C; Yang T; Li S; Li KL; Li D
Food Funct; 2020 Sep; 11(9):7389-7399. PubMed ID: 32966467
[TBL] [Abstract][Full Text] [Related]
12. Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: A systematic review and meta-analysis of clinical trials.
Mansour-Ghanaei F; Hadi A; Pourmasoumi M; Joukar F; Golpour S; Najafgholizadeh A
Phytother Res; 2018 Oct; 32(10):1876-1884. PubMed ID: 29947156
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease.
Sayari S; Neishaboori H; Jameshorani M
Clin Mol Hepatol; 2018 Sep; 24(3):331-338. PubMed ID: 29890569
[TBL] [Abstract][Full Text] [Related]
14. The effects of curcumin supplementation on body mass index, body weight, and waist circumference in patients with nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis of randomized controlled trials.
Baziar N; Parohan M
Phytother Res; 2020 Mar; 34(3):464-474. PubMed ID: 31799714
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Synbiotic Supplementation on Glucose Metabolism and Lipid Profiles in Patients with Diabetes: a Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Tabrizi R; Moosazadeh M; Lankarani KB; Akbari M; Heydari ST; Kolahdooz F; Asemi Z
Probiotics Antimicrob Proteins; 2018 Jun; 10(2):329-342. PubMed ID: 28677046
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis of the prebiotics and synbiotics effects on glycaemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity.
Beserra BT; Fernandes R; do Rosario VA; Mocellin MC; Kuntz MG; Trindade EB
Clin Nutr; 2015 Oct; 34(5):845-58. PubMed ID: 25456608
[TBL] [Abstract][Full Text] [Related]
17. Effects of pro-/synbiotic supplementation on anthropometric and metabolic indices in overweight or obese children and adolescents: A systematic review and meta-analysis.
Mohammadi H; Ghavami A; Hadi A; Askari G; Symonds M; Miraghajani M
Complement Ther Med; 2019 Jun; 44():269-276. PubMed ID: 31126565
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of synbiotic supplementation in obesity treatment: A systematic review and meta-analysis of clinical trials.
Hadi A; Alizadeh K; Hajianfar H; Mohammadi H; Miraghajani M
Crit Rev Food Sci Nutr; 2020; 60(4):584-596. PubMed ID: 30595036
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of probiotic and synbiotic supplementation on some cardiovascular risk factors among individuals with prediabetes and type 2 diabetes mellitus: A grade-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials.
Naseri K; Saadati S; Yari Z; Asbaghi O; Hezaveh ZS; Mafi D; Hoseinian P; Ashtary-Larky D; Hekmatdoost A; de Courten B
Pharmacol Res; 2022 Aug; 182():106288. PubMed ID: 35680009
[TBL] [Abstract][Full Text] [Related]
20. Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial.
Mofidi F; Poustchi H; Yari Z; Nourinayyer B; Merat S; Sharafkhah M; Malekzadeh R; Hekmatdoost A
Br J Nutr; 2017 Mar; 117(5):662-668. PubMed ID: 28345499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
